國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Hepatocellular carcinomatranslationa...

Hoshida, Yujin.

Hepatocellular carcinomatranslational precision medicine approaches /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Hepatocellular carcinomaedited by Yujin Hoshida.
其他題名:	translational precision medicine approaches /
其他作者:	Hoshida, Yujin.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	xv, 364 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	LiverCancer.
電子資源:	https://doi.org/10.1007/978-3-030-21540-8
ISBN:	9783030215408$q(electronic bk.)

Hepatocellular carcinomatranslational precision medicine approaches /
Hepatocellular carcinomatranslational precision medicine approaches /[electronic resource] :edited by Yujin Hoshida. - Cham :Springer International Publishing :2019. - xv, 364 p. :ill., digital ;24 cm. - Molecular and translational medicine,2197-7852. - Molecular and translational medicine..

Part 1: Clinical demographics and management -- 1. Risk Factors of Hepatocellular Carcinoma for Precision Personalized Care -- 2. Hepatocellular Carcinoma Surveillance and Staging -- 3. Changing Epidemiology of Hepatocellular Carcinoma and Role of Surveillance -- Part 2: Diagnosis and prognostication -- 4. Radiological diagnosis and characterization of HCC -- 5. Analysis of Hepatocellular Carcinoma Tissue for Biomarker and Therapeutic Target Discovery -- 6. Molecular subtypes and genomic signatures of hepatocellular carcinoma for prognostication and therapeutic decision making -- 7. Liquid Biopsy in Hepatocellular Carcinoma -- Part 3: Treatment -- 8. Surgical Therapies in Hepatocellular Carcinoma -- 9. Interventional Radiologic Therapies for Hepatocellular Carcinoma: From Where We Began To Where We Are Going -- 10. Precision Locoregional Therapies for Hepatocellular Carcinoma: Percutaneous Ablation and Radiotherapy -- 11. Molecular-targeted therapies in hepatocellular carcinoma -- 12. Immune therapies -- 13. Prevention Strategies for Hepatocellular Carcinoma -- Part 4: Molecular pathogenesis and therapeutic discovery -- 14. Molecular Alterations and Heterogeneity in Hepatocellular Carcinoma -- 15. Stromal and Immune Drivers of Hepatocarcinogenesis -- 16. Experimental Models for Preclinical Research in Hepatocellular Carcinoma.

This book provides a comprehensive overview of the current limitations and unmet needs in Hepatocellular Carcinoma (HCC) diagnosis, treatment, and prevention. It also provides newly emerging concepts, approaches, and technologies to address challenges. Topics covered include changing landscape of HCC etiologies in association with health disparities, framework of clinical management algorithm, new and experimental modalities of HCC diagnosis and prognostication, multidisciplinary treatment options including rapidly evolving molecular targeted therapies and immune therapies, multi-omics molecular characterization, and clinically relevant experimental models. The book is intended to assist collaboration between the diverse disciplines and facilitate forward and reverse translation between basic and clinical research by providing a comprehensive overview of relevant areas, covering epidemiological trend and population-level patient management strategies, new diagnostic and prognostic tools, recent advances in the standard care and novel therapeutic approaches, and new concepts in pathogenesis and experimental approaches and tools, by experts and opinion leaders in their respective fields. By thoroughly and concisely covering whole aspects of HCC care, Hepatocellular Carcinoma serves as a valuable reference for multidisciplinary readers, and promotes the development of personalized precision care strategies that lead to substantial improvement of disease burden and patient prognosis in HCC.

ISBN: 9783030215408$q(electronic bk.)

Standard No.: 10.1007/978-3-030-21540-8doiSubjects--Topical Terms:

273798
Liver
--Cancer.

LC Class. No.: RC280.L5 / H46 2019

Dewey Class. No.: 616.99436

Hepatocellular carcinomatranslational precision medicine approaches /
LDR:03938nmm a2200349 a 4500 001 565043
003 DE-He213
005 20191027131159.0
006 m d
007 cr nn 008maaau
008 200327s2019 gw s 0 eng d
020 $a 9783030215408$q(electronic bk.)
020 $a 9783030215392$q(paper)
024 7 $a 10.1007/978-3-030-21540-8 $2 doi
035 $a 978-3-030-21540-8
039 0 2 $a nam a2200337 a 4500
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.L5 $b H46 2019
072 7 $a MMF $2 bicssc
072 7 $a MED067000 $2 bisacsh
072 7 $a MKF $2 thema
082 0 4 $a 616.99436 $2 23
090 $a RC280.L5 $b H529 2019
245 0 0 $a Hepatocellular carcinoma $h [electronic resource] : $b translational precision medicine approaches / $c edited by Yujin Hoshida.
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana, $c 2019.
300 $a xv, 364 p. : $b ill., digital ; $c 24 cm.
490 1 $a Molecular and translational medicine, $x 2197-7852
505 0 $a Part 1: Clinical demographics and management -- 1. Risk Factors of Hepatocellular Carcinoma for Precision Personalized Care -- 2. Hepatocellular Carcinoma Surveillance and Staging -- 3. Changing Epidemiology of Hepatocellular Carcinoma and Role of Surveillance -- Part 2: Diagnosis and prognostication -- 4. Radiological diagnosis and characterization of HCC -- 5. Analysis of Hepatocellular Carcinoma Tissue for Biomarker and Therapeutic Target Discovery -- 6. Molecular subtypes and genomic signatures of hepatocellular carcinoma for prognostication and therapeutic decision making -- 7. Liquid Biopsy in Hepatocellular Carcinoma -- Part 3: Treatment -- 8. Surgical Therapies in Hepatocellular Carcinoma -- 9. Interventional Radiologic Therapies for Hepatocellular Carcinoma: From Where We Began To Where We Are Going -- 10. Precision Locoregional Therapies for Hepatocellular Carcinoma: Percutaneous Ablation and Radiotherapy -- 11. Molecular-targeted therapies in hepatocellular carcinoma -- 12. Immune therapies -- 13. Prevention Strategies for Hepatocellular Carcinoma -- Part 4: Molecular pathogenesis and therapeutic discovery -- 14. Molecular Alterations and Heterogeneity in Hepatocellular Carcinoma -- 15. Stromal and Immune Drivers of Hepatocarcinogenesis -- 16. Experimental Models for Preclinical Research in Hepatocellular Carcinoma.
520 $a This book provides a comprehensive overview of the current limitations and unmet needs in Hepatocellular Carcinoma (HCC) diagnosis, treatment, and prevention. It also provides newly emerging concepts, approaches, and technologies to address challenges. Topics covered include changing landscape of HCC etiologies in association with health disparities, framework of clinical management algorithm, new and experimental modalities of HCC diagnosis and prognostication, multidisciplinary treatment options including rapidly evolving molecular targeted therapies and immune therapies, multi-omics molecular characterization, and clinically relevant experimental models. The book is intended to assist collaboration between the diverse disciplines and facilitate forward and reverse translation between basic and clinical research by providing a comprehensive overview of relevant areas, covering epidemiological trend and population-level patient management strategies, new diagnostic and prognostic tools, recent advances in the standard care and novel therapeutic approaches, and new concepts in pathogenesis and experimental approaches and tools, by experts and opinion leaders in their respective fields. By thoroughly and concisely covering whole aspects of HCC care, Hepatocellular Carcinoma serves as a valuable reference for multidisciplinary readers, and promotes the development of personalized precision care strategies that lead to substantial improvement of disease burden and patient prognosis in HCC.
650 0 $a Liver $x Cancer. $3 273798
650 1 4 $a Pathology. $3 196513
650 2 4 $a Oncology. $3 195181
650 2 4 $a Gastroenterology. $3 274091
650 2 4 $a Hepatology. $3 274979
700 1 $a Hoshida, Yujin. $3 850788
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Molecular and translational medicine. $3 560124
856 4 0 $u https://doi.org/10.1007/978-3-030-21540-8
950 $a Medicine (Springer-11650)